IRIS
GIANNINI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.175
EU - Europa 1.963
AS - Asia 692
SA - Sud America 151
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.152
RU - Federazione Russa 455
GB - Regno Unito 453
IT - Italia 302
IE - Irlanda 239
SG - Singapore 207
CN - Cina 180
SE - Svezia 128
BR - Brasile 126
FR - Francia 100
DE - Germania 93
HK - Hong Kong 77
VN - Vietnam 75
UA - Ucraina 58
IN - India 49
FI - Finlandia 38
ES - Italia 33
ZA - Sudafrica 25
TR - Turchia 18
BD - Bangladesh 15
BE - Belgio 13
NL - Olanda 13
CA - Canada 11
PL - Polonia 10
IR - Iran 8
JP - Giappone 8
UZ - Uzbekistan 8
AR - Argentina 7
GR - Grecia 7
MX - Messico 7
SA - Arabia Saudita 7
KR - Corea 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
EG - Egitto 4
NG - Nigeria 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AT - Austria 3
EC - Ecuador 3
ID - Indonesia 3
OM - Oman 3
PK - Pakistan 3
BO - Bolivia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 5.022
Salva come PNG Salva come JPEG
Città #
Southend 398
Dallas 337
Dublin 238
Fairfield 234
Ashburn 153
Chandler 147
Moscow 135
Singapore 105
Woodbridge 91
Beijing 85
Santa Clara 84
Cambridge 80
Houston 80
Seattle 80
San Jose 75
Hong Kong 72
Siena 70
Ann Arbor 68
Wilmington 67
Jacksonville 49
New York 49
Princeton 39
Munich 38
Los Angeles 34
Ho Chi Minh City 27
Helsinki 25
Johannesburg 24
Rome 24
Milan 23
Lauterbourg 21
Málaga 21
Council Bluffs 19
San Mateo 16
Atlanta 15
Boardman 15
Dearborn 14
Hanoi 14
Brussels 13
São Paulo 13
Bengaluru 12
The Dalles 12
Izmir 11
Nanjing 11
San Diego 11
Fremont 10
Portsmouth 10
Buffalo 9
Manchester 9
Chennai 8
London 8
Orem 8
Redwood City 8
Tashkent 8
Amsterdam 7
Düsseldorf 7
Frankfurt am Main 7
Montreal 7
Mumbai 7
Redondo Beach 7
Tokyo 7
Espoo 6
Indianapolis 6
Seoul 6
Warsaw 6
Belo Horizonte 5
Brasília 5
Brescia 5
Brooklyn 5
Clifton 5
Da Nang 5
North Bergen 5
Rio de Janeiro 5
Riyadh 5
Shanghai 5
Abuja 4
Cagliari 4
Cairo 4
Changsha 4
Chicago 4
Dhaka 4
Florence 4
Jinan 4
Nanchang 4
Newark 4
Oklahoma City 4
Roccagorga 4
Salamanca 4
San Francisco 4
Tianjin 4
Turku 4
Baghdad 3
Brno 3
Chongqing 3
Como 3
Fort Worth 3
Haiphong 3
Hebei 3
Istanbul 3
Jiaxing 3
Kilburn 3
Totale 3.444
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 324
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 295
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 295
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 293
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 291
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 284
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 282
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 258
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 252
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 249
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 246
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 238
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 234
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 232
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 224
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 210
HIV drug discovery and resistance testing through cell based assays 205
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 197
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients 186
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 157
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 136
null 32
Totale 5.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 61 16 32
2021/2022482 26 59 35 51 34 28 31 28 28 42 41 79
2022/2023464 29 76 57 52 30 82 24 31 32 27 18 6
2023/2024414 14 6 35 35 4 109 139 15 1 4 5 47
2024/2025708 19 28 119 33 72 46 30 59 78 35 79 110
2025/20261.603 94 213 273 230 410 48 148 53 56 78 0 0
Totale 5.120